Onconova Therapeutics, Inc. carries a market capitalization of 20.90M, placing it among publicly traded companies globally.
| Market Cap | 20.90M |
| Enterprise Value | N/A |
Onconova Therapeutics, Inc.'s stock has declined approximately -6.98131% over the past 52 weeks. The 50-day moving average sits at 0.82, while the 200-day moving average is 0.78.
| Beta (5Y) | N/A |
| 52-Week Price Change | -6.98131% |
| 50-Day Moving Average | 0.82 |
| 200-Day Moving Average | 0.78 |
| Average Volume (20 Days) | N/A |
Onconova Therapeutics, Inc.'s most recent stock split took place on May 21, 2021 with a 15:1 split ratio.
| Last Split Date | 5/21/2021 |
| Split Ratio | 15:1 |